Abstract
BackgroundIn Juvenile Idiopathic Arthritis (JIA) patients Etanercept is an effective therapeutic agent with an excellent safety profile. Currently it is licensed for treatment in polyarticular JIA patients over the age...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
